Aileron Therapeutics
Why Robinhood?
You can watch ALRN and buy or sell other stocks, ETFs, and their options commission-free!About ALRN
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers.
ALRN Key Statistics
Stock Snapshot
The current Aileron Therapeutics(ALRN) stock price is $4.33, with a market capitalization of 121.41M. The stock trades at a price-to-earnings (P/E) ratio of -0.45.
Aileron Therapeutics(ALRN) stock opened on 2026-07-17 at —. The price climbed to — and dipped to —.
The Aileron Therapeutics(ALRN)'s current trading volume is 0, compared to an average daily volume of 299.31K.
In the last year, Aileron Therapeutics(ALRN) shares hit a 52-week high of $2.18 and a 52-week low of $0.86.
In the last year, Aileron Therapeutics(ALRN) shares hit a 52-week high of $2.18 and a 52-week low of $0.86.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.